Association Institut De Myologie

At the Association Institut De Myologie in Paris, research in this area focuses on Duchenne Muscular Dystrophy, a serious inherited condition that weakens muscles over time. The trials are designed to explore new ways to slow disease progression and support better long-term outcomes for affected patients.

• Testing a new gene therapy approach for boys who can still walk
• Assessing whether treatment can improve clinical effectiveness and maintain muscle function
• Evaluating the safety and tolerability of emerging therapies over time

This work combines genetic medicine and neuromuscular research to address the underlying cause of the disease while also monitoring how well patients respond to treatment.

Clinical research at this site also examines treatment options for Duchenne muscular dystrophy in patients with more advanced mobility loss. The main goal is to determine whether a new therapy can help reduce muscle decline and preserve remaining physical function.

• Evaluating a treatment intended to slow muscle deterioration
• Measuring treatment effectiveness in non-ambulant patients
• Studying the overall safety and tolerability of the therapy

These studies reflect an ongoing effort in musculoskeletal medicine to improve care for people living with progressive inherited muscle disease.